Targeted therapy of angiogenesis using anti-VEGFR2 and anti-NRP-1 nanobodies.
Elmira KaramiShamsi NaderiReyhaneh RoshanMahdi BehdaniFatemeh Kazemi-LomedashtPublished in: Cancer chemotherapy and pharmacology (2022)
Our results offer a promising role of combination therapies in cancer therapy as well as angiogenesis.